Not applicableUnknownNCT04984096What this trial is testingAnlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal CancerWho this might be right forEsophageal Cancer Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT00177255What this trial is testingDocetaxel in Combination With Capecitabine in Stomach and Esophagus CancersWho this might be right forCancer University of Pittsburgh 40
Not applicableActive Not RecruitingNCT06401447What this trial is testingTPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Fudan University 50
Testing effectiveness (Phase 2)UnknownNCT00995358What this trial is testingA Study With Peptide Vaccination in Treating Patients With Esophageal CancerWho this might be right forEsophageal Cancer University of Yamanashi 60
Not applicableUnknownNCT03896958What this trial is testingThe PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)Who this might be right forCancer, All TypesCancer of LiverCancer of Stomach+42 more SpeciCare 1,000
Testing effectiveness (Phase 2)UnknownNCT04389177What this trial is testingPembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001)Who this might be right forEsophageal Squamous Cell CarcinomaStage III Tianjin Medical University Cancer Institute and Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00006081What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT07692204What this trial is testingA Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction CancerWho this might be right forGastric CancerOesophageal Carcinoma Sanofi 30
Early research (Phase 1)Study completedNCT01561014What this trial is testingOxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach+5 more Wake Forest University Health Sciences 9
Testing effectiveness (Phase 2)UnknownNCT03139487What this trial is testingPhase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismWho this might be right forCancer-associated ThrombosisEsophageal CancerStomach Cancer+7 more Asan Medical Center 176
Testing effectiveness (Phase 2)Looking for participantsNCT06112704What this trial is testingHS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Hansoh BioMedical R&D Company 220
Early research (Phase 1)Study completedNCT00950417What this trial is testingNimotuzumab in Combination With Chemoradiation for Esophageal CancerWho this might be right forAdvanced Esophageal Biotech Pharmaceutical Co., Ltd. 11
Testing effectiveness (Phase 2)Ended earlyNCT01307956What this trial is testingPanitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction CancerWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionEsophageal AdenocarcinomaStage IIA Esophageal Cancer+1 more University of Nebraska 11
Testing effectiveness (Phase 2)Looking for participantsNCT06474468What this trial is testingA Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal CancerWho this might be right forAdvanced or Metastatic Esophageal Cancer Shanghai Hengrui Pharmaceutical Co., Ltd. 148
Early research (Phase 1)Study completedNCT04772989What this trial is testingEvaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesWho this might be right forAdvanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more Arcus Biosciences, Inc. 94
Early research (Phase 1)Study completedNCT00005638What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal CancerWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00109850What this trial is testingS0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal CancerWho this might be right forEsophageal Cancer SWOG Cancer Research Network 22
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07312578What this trial is testingNimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Peking University 48
Testing effectiveness (Phase 2)Study completedNCT03261947What this trial is testingEvaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid TumorsWho this might be right forMetastatic Pancreatic CancerColorectal CancerEsophageal Neoplasms+1 more Millennium Pharmaceuticals, Inc. 101